Thank you for this opportunity
@stoway.
If I read the sentiment in Australia correctly, it is, rightly or wrongly, that tthe COVID pandemic has passed. We are going into summer and the risk in that season is less. Europe is a different matter and they may see increased infection over their winter, particularly as they huddle together for warmth.
I have always been of the view that Viraleze should be promoted as a broad spectrum ani-viral, good for all the COVID varieties, Influenza, and some colds. The Scripps results should be front and centre, because companies like Vick and the red seaweed outfit cannot compete. I would also have Scripps do more comparative testing and then do what the company has not yet done, advertise the product.
They can only do that in countries where the product is approved, which leads us to the main thrust of your question. The Therapeutic Good Administration has become a law unto itself and, if COVID vaccines are anything to go by, immune to Ministerial pressure. No government body is immune to pressure so the pressure needs to be applied directly to politicians and through the media.
TGA lost out in the last spat and the delay which that appears to have caused might be seen as revenge, which everyone understands and will not support. The company should stay squeaky clean on this and say nothing except that it is responding to any requests from TGA as urgently as it can.
In the meantime it should be entertaining journalists and politicians as it never has before. Giving away boxes of Viraleze (You cannot sell it but you can give it away).
Lastly I would devise a clinical trial of Viraleze, one in which a fairly huge number of participants are provided with the spray and have to report any infection via a web site. I would then advertise the trial, which you are allowed to. Particularly, invite people planning to travel!
I am not privy to correspondence and other information which may invalidate the above.
